Psychedelics Headlines: Dementia Prevention, Psychological Flexibility, Ancient Romans’ Trips And More – Awakn Life Sciences (OTC:AWKNF), BetterLife Pharma (OTC:BETRF)

Welcome to Biedex Markets’s psychedelic headlines roundup. This is our pick of must-read news items from the first two weeks of April 2024.

See previous edition Psychedelics Headlines: A Form Of Life, Treating Chronic Pain, Microdosing And More

Research

• Psilocybin for dementia prevention? The potential role of psilocybin to alter mechanisms associated with major depression and neurodegenerative diseases (original read.)
• A pilot study of the effect of group-administered psilocybin on psychological flexibility and outcomes (original read.)
• The Promise of Therapeutic Psilocybin: An Evaluation of the 134 Clinical Trials, 54 Potential Indications, and 0 Marketing Approvals on ClinicalTrials.gov (original read.)
• Acute Adverse Effects of Therapeutic Doses of Psilocybin – A Systematic Review and Meta-Analysis (original read.)

Tune In, Get Smart

• What psychedelics legalization and decriminalization looks like around the world, by BBC’s Jennifer Chesak.
• Global Perspectives on Psychedelics Regulation, by The Regulatory Review.
• Why Psychedelic Therapy Needs Specially Trained Therapists, by Psychology Today.
• Childhood trauma, challenging experiences, and post traumatic growth in ayahuasca use, research published in Drug Science.
• Psychedelic Church Sues for Defamation After Lab Test Raises Hope for Presence of Novel Drug, by Mattha Busby for DoubleBlind.
• William James was right about our strange inner experiences, writes renowned researcher David Yaden for Psyche.
• Psychedelic music depicted on ancient Peruvian rock art, by David Pescovitz for Boingboing.
• Ancient Romans Used to Trip on Hallucinogenic Seeds, Archeologists Say (DoubleBlind.)
• Indigenous ketamine therapy: 5 Questions for First Nations mental health leader Emmy Manson, by the Microdose.
• Measuring the ineffable: 5 Questions for mystical experience researcher Kurt Stocker, by The Microdose.
• Insurance Coverage for Psychedelic Therapy, by Vincent Joralemon for Harvard’s Petrie Flom center.
• Magic mushrooms should be available on the NHS says Labour MP, story by The Telegraph.
• How Age Shapes the Psychedelic Experience, by The Chemical Collective.
• The Risks of Self-Medicating Alone with Psychedelics, by Sam Woolfe for Psychedelic Support.
• How Psychedelics Can Guide the Transformative Journey of Polyamory, by Chacruna Institute.
• How a Supreme Court Ruling Made Blotter Paper Beloved Among Acid Dealers Everywhere, by Mary Carreon for DoubleBlind.
• Psychedelic Theodicy: The Tendency to Deny and Downplay the Harms of Psychedelics, by Sam Woolfe.
• Business Trip’s latest podcast episode “Comparing Psychedelic Compounds in Therapy” (Live Panel at Battery SF), with Nolan Williams, Allison Feduccia and Matt Baggot (listen.)
• “From post-Nazi Germany to America’s War on Drugs,” a podcast conversation between Prof. David Nutt and author Norman Ohler (listen.)
• “Psychedelics and cult dynamics,” a conversation conducted by researcher Jules Evans, will be online on April 17 (register.) 
• Psycon’s 2024 edition will take place in Colorado from May 9-11 (info.)
• The 4th Annual Psychedelic Therapeutics and Drug Development Conference will take place in Boston on May 23-24 (info.)

Panorama Pulse